LifeMD Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, LifeMD stock has a consensus rating of "Strong Buy" and an average price target of $9.88. The average 1-year stock price forecast is 105.19% higher than the current stock price, while the lowest is $8.00 (+66.15%) and the highest is $15 (+211.53%).

Price Target: $9.88 (+105.19%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$9.88	$10	$15
Change	+66.15%	+105.19%	+107.68%	+211.53%

Analyst Ratings

The average analyst rating for LifeMD stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	7	7	7	8	8	8
Buy	0	0	0	0	0	0
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $10	Buy	Reiterates	$10	+107.68%	May 26, 2026
Ryan Meyers Lake Street	Lake Street	Buy Reiterates $8	Buy	Reiterates	$8	+66.15%	May 7, 2026
David Larsen BTIG	BTIG	Buy Reiterates $10	Buy	Reiterates	$10	+107.68%	May 7, 2026
Steven Valiquette Mizuho Securities	Mizuho Securities	Buy Upgrades $6 → $8	Buy	Upgrades	$6 → $8	+66.15%	Mar 16, 2026
Scott Schoenhaus KeyBanc	KeyBanc	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Mar 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

222.05M

from 194.06M

14.42%

from 194.06M

Revenue Next Year

260.90M

from 222.05M

17.50%

from 222.05M

EPS This Year

0.14

from 0.15

-7.85%

from 0.15

EPS Next Year

0.52

from 0.14

281.48%

from 0.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	92.88M	119.03M	152.55M	154.82M	194.06M	222.05M
Revenue Growth	149.04%	28.16%	28.16%	1.49%	25.34%	14.42%
Gross Profit	74.88M	100.37M	133.65M	133.38M	166.34M	193.49M
Gross Margin	80.62%	84.32%	87.61%	86.15%	85.72%	87.14%
Operating Income	-54.30M	-39.69M	-14.49M	-20.40M	-7.67M	-9.57M
Net Income	-60.90M	-45.54M	-20.60M	-21.41M	14.35M	-13.11M
EPS	-	-	-	-	0.15	0.14
EPS Growth	-	-	-	-	-58.14%	-7.85%
Forward PE	-	-	-	-	-	35.67
Free Cash Flow	-15.46M	-19.08M	4.47M	11.04M	-10.16M	13.10M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	224.0M
Avg	222.0M
Low	220.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	15.4%
Avg	14.4%
Low	13.5%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.14
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-7.8%
Low	-